8-K current report · filed Sep 29, 2026

DYNEX CAPITAL INC (DX) 8-K Current Report: September 29, 2026

Item 3.03Item 5.03Item 8.01DX overview

Short answer

DYNEX CAPITAL INC (DX) filed an 8-K current report with the SEC on September 29, 2026 reporting Item 3.03 (Material Modification to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 8.01 (Other Events). Series D designation effective September 29, 2026, authorizing 5,520,000 preferred shares for the offering.

DYNEX CAPITAL INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 3.03 · Material Modification to Rights of Security Holders

  • Series D designation effective September 29, 2026, authorizing 5,520,000 preferred shares for the offering
  • 9.375% cumulative dividend, $2.34375 annually per share on the $25 liquidation preference
  • Initial issuance 4,800,000 shares, with underwriters’ option for 720,000 additional shares
  • Senior to common equity, pari passu with Series C preferred, but junior to all company and subsidiary debt
  • No redemption before October 15, 2031 except change-of-control or REIT/REMIC tax protections; six missed quarterly dividends trigger two director seats

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

  • Item 5.03 incorporates Item 3.03, so the amendment’s shareholder-rights implications must be assessed there
  • Investors should review Item 3.03 for the specific Articles of Amendment and effective date

Item 8.01 · Other Events

  • Offering closed September 29, 2026, completing the previously announced issuance and sale of underwritten shares
  • Morrison & Foerster LLP provided legal and tax opinions supporting the share issuance
  • Expected net proceeds and intended use remain forward-looking, subject to execution and market risks

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other DYNEX CAPITAL INC 8-K filings

Get the next DX 8-K as it lands

Follow DX for push alerts, or ask the research agent what this filing means.